These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1114 related items for PubMed ID: 7566978

  • 1. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
    Reymond A, Brent R.
    Oncogene; 1995 Sep 21; 11(6):1173-8. PubMed ID: 7566978
    [Abstract] [Full Text] [Related]

  • 2. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC.
    Nat Genet; 1995 May 21; 10(1):114-6. PubMed ID: 7647780
    [Abstract] [Full Text] [Related]

  • 3. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 4. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM, Rizos H, Kefford RF, Mann GJ.
    Clin Cancer Res; 2001 Oct 01; 7(10):3282-8. PubMed ID: 11595726
    [Abstract] [Full Text] [Related]

  • 5. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 01; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul 01; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 01; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 9. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N.
    Oncogene; 2000 Mar 30; 19(14):1849-52. PubMed ID: 10777219
    [Abstract] [Full Text] [Related]

  • 10. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ, Li Y, Xiong Y, Guan KL.
    Cancer Res; 1999 Feb 01; 59(3):558-64. PubMed ID: 9973200
    [Abstract] [Full Text] [Related]

  • 11. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells.
    Welcker M, Lukas J, Strauss M, Bartek J.
    Cancer Res; 1998 Nov 15; 58(22):5053-6. PubMed ID: 9823309
    [Abstract] [Full Text] [Related]

  • 14. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 09; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 17. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT.
    Br J Cancer; 1999 Apr 09; 80(1-2):295-300. PubMed ID: 10390011
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A, Massagué J.
    Nature; 1997 May 22; 387(6631):417-22. PubMed ID: 9163429
    [Abstract] [Full Text] [Related]

  • 20. Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
    Ceha HM, Nasser I, Medema RH, Slebos RJ.
    Biochem Biophys Res Commun; 1998 Aug 19; 249(2):550-5. PubMed ID: 9712735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.